×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Cancer Screening and Treatment

Issues & Solutions

Direct Relief partners with leading cancer treatment companies to provide life-saving medicines to underserved patients throughout the world

Staff prepare medications at Hiwa Cancer Hospital, the only specialized cancer hosital in Iraqi Kurdistan, and the second-largest provider of cancer care in all of Iraq. In partnership with Kurdistan Save the Children, a donation of requested chemotherapy medicine from Direct Relief was delivered to the hospital in January 2019. (Photo courtesy of Kurdistan Save the Children)

Quick Facts

Cancer is the second leading cause of death globally

Approximately 70% of deaths from cancer occur in low- and middle-income countries, according to the UN World Health Organization

Direct Relief partners with leading cancer treatment companies to provide access to life-saving cancer treatment to more than 50 public cancer hospitals around the world

How Direct Relief Expands Global Access to Cancer Care

Cancer network

Direct Relief partners with leading biotechnology and pharmaceutical companies, as well as cancer institutions, around the world, to source and deliver lifesaving treatments for patients in need. For more than 15 years, Direct Relief has supported cancer patients in over 50 countries, providing more than 1.5 billion defined daily doses of cancer treatments and associated therapeutic agents.

City cancer challenge

As a member of the Union for International Cancer Control (UICC), Direct Relief has partnered with Amgen and the City Cancer Challenge (C/Can) — an initiative that supports cities around the world to improve access to quality, equitable cancer care  — to advance access to cancer treatments in five low- and middle-income countries across Africa, Asia, and Latin America and the Caribbean. With a shared mission of transforming the way public and private stakeholders work together to design, plan and implement cancer care solutions in cities, the joint partnership is collaborating to strengthen health infrastructures and capacities for cancer diagnosis, treatment and care.

C/Can Paraguay: Improving Health Outcomes for Breast Cancer Patients 

Through its partnerships with Amgen and C/Can, Direct Relief is working to improve health outcomes for breast cancer patients in Paraguay’s capital city of Asunción. In addition to delivering critical cancer diagnostics and treatments, the joint partnership is engaging local stakeholders to strengthen health infrastructure, the healthcare workforce, surveillance capacity, and palliative and supportive care at Paraguay’s leading cancer treatment institutions.

For more than 25 years, Direct Relief has supported healthcare providers in Paraguay to expand access to essential treatments for cancer and other communicable and non-communicable diseases through the provision of donated medicines and medical supplies. Most recently, Direct Relief supplied Paraguayan hospitals and community health workers on the frontlines of the COVID-19 pandemic with critical medicines and supplies, including personal protective equipment, to bolster the country’s capacity to care for patients and reduce disease transmission.  

Learn More

Global Hope

Direct Relief partners with Global Hematology Oncology Pediatric Excellence (Global HOPE), an initiative of Texas Children’s Hospital and Baylor College of Medicine, and Teva Pharmaceuticals to expand access to lifesaving cancer therapies and improve the prognosis of children with cancer and blood disorders in sub-Saharan Africa. Since 2019, Direct Relief has provided more than 180,000 defined daily doses of critical cancer treatments in support of the initiative, reaching pediatric patients in Botswana, Malawi, Tanzania and Uganda.

“Thanks to this collaboration, children who would otherwise be unable to access cancer therapies will be able to receive the treatments they need.”

–Thomas Tighe, President and CEO of Direct Relief

Learn More

pediatric cancer care in mexico

Since 2016, Direct Relief has partnered with the AbbVie Foundation and Casa de la Amistad para Niños con Cáncer (CDLA) — a humanitarian organization based in Mexico City that provides services, including counseling, education, nutritional support, shelter and transportation, to children with cancer and their families — to help under-resourced families in Mexico overcome barriers that prevent many children with cancer from accessing and adhering to treatment.  In coordination with the AbbVie Foundation and CDLA, Direct Relief supports more than 300 pediatric patients from rural communities with stipends for food, lodging and transportation, reducing the costs associated with traveling to and receiving cancer care at hospitals.

LEARN MORE ABOUT DIRECT RELIEF’S WORK IN MEXICO

Partnership Spotlight

Giving is Good Medicine

You don’t have to donate. That’s why it’s so extraordinary if you do.